Improving immunotherapy delivery by bringing order to tumor blood vesselsnews2021-11-09T14:47:25+00:00November 9th, 2021|Fierce Pharma|
With filing in sight, Opiant’s nasal opioid overdose drug boards FDA fast tracknews2021-11-09T14:43:27+00:00November 9th, 2021|Fierce Pharma|
Genentech backs song created by and for people with spinal muscular atrophy to elevate people with disabilitiesnews2021-11-09T14:34:39+00:00November 9th, 2021|Fierce Pharma|
Biohaven taps Pfizer for global Nurtec push in deal worth up to $1.24Bnews2021-11-09T14:24:40+00:00November 9th, 2021|Fierce Pharma|
With Merck’s oral COVID-19 med molnupiravir set for authorization, U.S. spends another $1B for 1.4 million coursesnews2021-11-09T13:56:07+00:00November 9th, 2021|Fierce Pharma|
With Merck’s oral COVID-19 med molnupiravir set for authorization, U.S. spends another $1B for 1.4M coursesnews2021-11-09T13:56:07+00:00November 9th, 2021|Fierce Pharma|
Almac on global hiring binge for 1,800 new positions as the CDMO expandsnews2021-11-09T12:44:03+00:00November 9th, 2021|Fierce Pharma|
GSK’s ViiV turns to Black women’s experiences in latest season of award-winning podcastnews2021-11-09T07:39:14+00:00November 9th, 2021|Fierce Pharma|
Samsung Pharm hit with 3-month production suspension from Korean regulatorsnews2021-11-08T17:07:35+00:00November 8th, 2021|Fierce Pharma|
Lilly and Boehringer’s Jardiance shows benefits for those with ‘intimately linked’ heart failure and kidney diseasenews2021-11-08T16:18:06+00:00November 8th, 2021|Fierce Pharma|
